80020811: The Fifth Bi-annual Johns Hopkins Breast Cancer Conference: Controversies in Management-a Multidisciplinary Perspective

Click here for a text version of the brochure
Text version of brochure

ACCREDITATION STATEMENT
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of The Johns Hopkins University School of Medicine and The Institute for Johns Hopkins Nursing. The Johns Hopkins University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians. Credit Designation Statement The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 12.25 AMA PRA Category 1 Credits®. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Nursing Credit
AANC: The Institute for Johns Hopkins Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This program is pending approval of The Institute for Johns Hopkins Nursing.
AANP: The Institute for Johns Hopkins Nursing is approved as a provider of nurse practitioner continuing education by the American Academy of Nurse Practitioners: AANP Provider Number 061216. This program is pending approval of The Institute for Johns Hopkins Nursing
OTHER CREDIT
American Academy of Physician Assistants (AAPA) AAPA accepts AMA Category 1 CME credit for the PRA from organizations accredited by ACCME. Contact Hours for Non-Physicians The Johns Hopkins University has approved this activity for 12.25 contact hours for non-physicians.

Description:
The incidence of breast cancer in the United States exceeds 250,000 women for the year 2009. This number continues to grow as baby boomers enter midlife, increasing the population denominator. Also, 41,000 women died of this disease in 2009. Despite there being specific standards of care and treatment correlated with specific diagnostic stages of the disease, in actual practice, there continues to be controversy as to the most appropriate management of some breast cancer patients. This can be due in part to the comorbidities the patient may have that accompany her disease, the age of the patient, compliance of the patient with the recommended treatment plan or other factors. Based on feedback from the last bi-annual breast cancer conference held, controversy in the selection of the treatment plan and delivery of care may also be dependent on the knowledge and experience of the treating physician(s). The goal of this conference is to discuss the management of controversial issues that affect all disciplines including surgical, medical, radiation, pathology, breast imaging, plastic surgery, and genetics. Presentations will engage the audience in active participation through pre and post opinion electronic-generated surveys and speakers will provide a pros and cons discussion regarding each topic discussed. The outcome should be a better understanding of the management of patients in the presence of unusual clinical presentations. Some outcomes will be the reduction in the use of healthcare resources that result in over-utilization of tests/scans, improvements in quality of care and more effective management of patients.

Objectives:
After attending this activity, the participant will demonstrate the ability to:
- Recognize the clinical issues of controversy related to the diagnosis and treatment of breast cancer patients.
- Identify ways to incorporate learned knowledge from the conference to apply in your own practice setting
- Discuss the rationale for the differences of opinion regarding the management of breast cancer.

Talks

Policy On Speaker And Provider Disclosure

It is the policy of the Johns Hopkins University School of Medicine that the speaker and provider disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s). Johns Hopkins University School of Medicine OCME has established policies in place that will identify and resolve all conflicts of interest prior to this educational activity. Detailed disclosure will be made in the activity handout materials.